At the TIDES Europe conference in Amsterdam this week, Celltrion and Scohia Pharma presented
At the TIDES Europe conference in Amsterdam this week, Celltrion and Scohia Pharma presented preclinical data for a new obesity drug candidate, CT-G32/SCO-940, that targets four hormone receptors simultaneously. According … Read More